Featured Research

from universities, journals, and other organizations

New drug blocks morphine's effects on breathing -- but not on pain

Date:
October 7, 2010
Source:
International Anesthesia Research Society (IARS)
Summary:
A new drug called repinotan blocks the respiratory depressant effects of morphine-like opioid drugs -- without altering their potent pain-relieving effects, according to a new study.

A new drug called repinotan blocks the respiratory depressant effects of morphine-like opioid drugs -- without altering their potent pain-relieving effects, according to a study in the October issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

If the promising results of animal studies are borne out by future research, then repinotan could become an important part of safe, effective pain control after surgery. The new study was led by Dr. Ulf Guenther of University of Ulm, Germany.

Subcutaneous Oxygen Levels during Surgery Predicts Later Infection Risk The researchers performed a series of experiments to see how repinotan influenced the effects of morphine. Although morphine and related drugs (opioids) are highly effective in treating pain after surgery, they share a common characteristic: they decrease the drive to breathe. This is a potentially serious side effect that can limit the use of opioid drugs for pain control.

In the study, rats were given a morphine dose high enough to slow the breathing rate. When the animals were subsequently treated with repinotan, their respiratory rate rapidly returned toward normal.

At the same time, repinotan did not alter the pain-blocking effects of morphine. This is especially important because, although other drugs are available to reverse the respiratory depressant effects of opioids, they also reverse the pain-relieving effects.

There were no serious cardiovascular side effects with repinotan, although it did cause a drop in blood pressure.

"For years, investigators have tried to develop an opioid that produced the profound analgesia of morphine, but without the effects on breathing rate," explains Dr. Steven L. Shafer of Columbia University, Editor-in-Chief of Anesthesia & Analgesia. More recently, specific types of drugs have been developed that selectively reverse morphine-induced depression of breathing. Repinotan is the first drug of this type that has proven suitable for studies in humans.

"This is an incredibly exciting development in opioid pharmacology," Dr. Shafer adds. "A drug that blocks the ability of opioids to suppress breathing, while not interfering with the pain relief, would be a huge advance in pain management and patient safety. Unless the drug had other toxicities, such a drug would immediately become the standard of care for post-operative patients receiving opioids."


Story Source:

The above story is based on materials provided by International Anesthesia Research Society (IARS). Note: Materials may be edited for content and length.


Journal Reference:

  1. U. Guenther et al. Repinotan, a Selective 5-HT1A-R-Agonist, Antagonizes Morphine-Induced Ventilatory Depression in Anesthetized Rats. Anesthesia & Analgesia, 2010 DOI: 10.1213/%u200BANE.0b013e3181eac011

Cite This Page:

International Anesthesia Research Society (IARS). "New drug blocks morphine's effects on breathing -- but not on pain." ScienceDaily. ScienceDaily, 7 October 2010. <www.sciencedaily.com/releases/2010/10/101006132741.htm>.
International Anesthesia Research Society (IARS). (2010, October 7). New drug blocks morphine's effects on breathing -- but not on pain. ScienceDaily. Retrieved September 16, 2014 from www.sciencedaily.com/releases/2010/10/101006132741.htm
International Anesthesia Research Society (IARS). "New drug blocks morphine's effects on breathing -- but not on pain." ScienceDaily. www.sciencedaily.com/releases/2010/10/101006132741.htm (accessed September 16, 2014).

Share This



More Computers & Math News

Tuesday, September 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

FBI Finishes $1 Billion Facial Recognition System

FBI Finishes $1 Billion Facial Recognition System

Newsy (Sep. 15, 2014) The FBI announced it plans to make its Next Generation Identification System available to law enforcement, but some privacy advocates are worried. Video provided by Newsy
Powered by NewsLook.com
A+ for Apple iPhone Pre-Sales

A+ for Apple iPhone Pre-Sales

Reuters - Business Video Online (Sep. 15, 2014) Apple says it received a record 4 million first-day pre-orders for its new iPhone 6 and iPhone 6 Plus, pushing delivery dates into October. Bobbi Rebell reports. Video provided by Reuters
Powered by NewsLook.com
Microsoft to Buy 'Minecraft' Maker for $2.5B

Microsoft to Buy 'Minecraft' Maker for $2.5B

AP (Sep. 15, 2014) Microsoft will acquire the maker of the long-running hit game Minecraft for $2.5 billion as the company continues to invest in its Xbox gaming platform and looks to grab attention on mobile phones. (Sept. 15) Video provided by AP
Powered by NewsLook.com
Manufacturer Prints 3-D Car In Record Time

Manufacturer Prints 3-D Car In Record Time

Newsy (Sep. 15, 2014) Automobile manufacturer Local Motors created a drivable electric car using a 3-D printer. Printing the body only took 44 hours. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

      Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins